1-Oxo-3,4-dihydroisoquinoline-4-carboxamides as novel druglike inhibitors of poly(ADP-ribose) polymerase (PARP) with favourable ADME characteristics
作者:Alexander Safrygin、Petr Zhmurov、Dmitry Dar’in、Sergey Silonov、Mariia Kasatkina、Yulia Zonis、Maxim Gureev、Mikhail Krasavin
DOI:10.1080/14756366.2021.1972993
日期:2021.1.1
scaffold was designed as the basis for the development of novel inhibitors of poly(ADP-ribose) polymerase (PARP). Synthesis of 3,4-dihydroisoquinol-1-one-4-carboxylic acids was achieved using the previously developed protocol based on the modified Castagnoli-Cushman reaction of homophthalic anhydrides and 1,3,5-triazinanes as formaldimine synthetic equivalents. Employment of 2,4-dimethoxy groups on the nitrogen
摘要 一种新型 3,4-二氢异羟基喹啉-1-one-4-carboxamide 支架被设计为开发新型聚 (ADP-核糖) 聚合酶 (PARP) 抑制剂的基础。3,4-二氢异喹啉-1-one-4-羧酸的合成是使用先前开发的协议实现的,该协议基于同邻苯二甲酸酐和 1,3,5-三嗪烷作为甲醛亚胺合成等价物的改良 Castagnoli-Cushman 反应。在后者的氮原子上使用 2,4-二甲氧基允许制备 2,3-未取代的 3,4-二氢喹诺酮核心构件。由这些羧酸的酰胺化产生的酰胺的迭代合成和体外生物测试不仅允许绘制重要的结构-活性概括(由in silico证实)对接模拟)以及先导化合物 4-([1,4'-bipiperidine]-1'-carbonyl)-7-fluoro-3,4-dihydroisoquinolin-1(2 H )-one的鉴定,作为进一步临床前开发的候选者。先导化合物及其脱氟类似物与获批的